Revenue: As of FY2025, the actual value is USD 0.EPS: As of FY2025, the actual value is USD -32.15, beating the estimate of USD -49.5.EBIT: As of FY2025, the actual value is USD -17.61 M.<h3>Segment Revenue</h3><ul><li>No product revenue was recognized for the fiscal year ended June 30, 2025, compared to $4,490,090 for the fiscal year ended June 30, 2024, due to the sale of Vyleesi’s worldwide rights to Cosette during fiscal 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Net Loss: The net loss for the year ended June 30, 2025, was $17.3 million, compared to $29.7 million for the year ended June 30, 2024.</li><li>Research and Development Expenses: Total research and development expenses were $14,898,494 for fiscal 2025, compared to $22,400,372 for fiscal 2024, primarily due to lower spending on MCR programs.</li><li>Selling, General and Administrative Expenses: These expenses were $7,809,345 for fiscal 2025, compared to $12,270,046 for fiscal 2024, primarily due to decreased compensation costs and selling expenses related to Vyleesi.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Used in Operating Activities: $21,306,637 for fiscal 2025, compared to $31,461,441 in fiscal 2024, reflecting a lower net loss and gains on the sale of Vyleesi and purchase commitments.</li><li>Net Cash Provided by Investing Activities: $3,130,000 related to proceeds from the sale of Vyleesi for fiscal 2025, compared to $12,450,364 for fiscal 2024.</li><li>Net Cash Provided by Financing Activities: $11,213,506 for fiscal 2025, compared to $20,548,891 for fiscal 2024, primarily from the sale of common stock and warrants and the exercise of outstanding warrants.</li></ul><h3>Unique Metrics</h3><ul><li>Gain on Sale of Vyleesi: Recorded a gain of $3,130,000 for fiscal 2025, compared to $7,781,844 for fiscal 2024.</li><li>Gain on Purchase Commitment: $2,117,900 for fiscal 2025 due to the amendment of minimum purchase commitments.</li></ul><h3>Outlook / Guidance</h3><ul><li>The company anticipates incurring significant expenses in the future due to spending on development programs and will require substantial additional financing or revenues to continue funding its planned activities.</li><li>Based on current operating and development plans, existing cash and cash equivalents are expected to fund anticipated operating expenses through the second half of calendar year 2025.</li></ul>

Palatin Technologies, Inc. | 10-K: FY2025 Revenue: USD 0